Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasm, Residual
|
23 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Neurilemmoma
|
11 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Noonan Syndrome
|
187 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Papillary and follicular adenocarcinoma
|
2 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Papillary carcinoma, clear cell
|
2 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Poorly differentiated carcinoma
|
2 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Primary cholangiocarcinoma of intrahepatic biliary tract
|
10 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Sebaceous adenoma
|
6 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Secondary malignant neoplasm of bone
|
18 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Secondary malignant neoplasm of liver
|
34 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Split hand foot deformity 1
|
8 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Squamous cell carcinoma
|
257 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Thyroid Nodule
|
17 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Adenomatous Polyposis Coli
|
237 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
MUTYH-Associate Polyposis
|
36 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
polyps
|
18 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||||
Malignant neoplasm of pancreas
|
277 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Pancreatic carcinoma
|
322 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Adenocarcinoma
|
168 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2016 | 2018 | ||||||
Colorectal Carcinoma
|
1962 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.040 | 0.750 | 4 | 2015 | 2019 | ||||||
Primary malignant neoplasm
|
1374 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2012 | 2020 | ||||||
Malignant Neoplasms
|
1641 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.050 | 1.000 | 5 | 2012 | 2020 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.070 | 1.000 | 7 | 2011 | 2019 | ||||||
Neoplasms
|
1644 | 0.583 | 0.640 | 12 | 25245351 | missense variant | C/A;G;T | snv | 0.100 | 1.000 | 15 | 2011 | 2019 |